Electroporation advances in large animals

Current Gene Therapy

Volumn 9, Issue 4, 2009, Pages 316-326

  Reed, Scott D ^a   Li, Shulin ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

DNA vaccine; Electroporation; Gene delivery; Gene expression; Gene therapy; Large animals

Indexed keywords

DENDRITIC CELL VACCINE; DNA VACCINE; GLUCAGON LIKE PEPTIDE 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR VACCINE; GROWTH HORMONE RELEASING FACTOR; INTERLEUKIN 2; LEPTIN; LIPOPOLYSACCHARIDE; PLASMID DNA; PROSTATE SPECIFIC ANTIGEN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ADJUVANT THERAPY; ANTIGEN PRESENTING CELL; CELLULAR IMMUNITY; ECHOGRAPHY; ELECTROPORATION; GENE CONSTRUCT; GENE EXPRESSION; GENE THERAPY; HEPATITIS B; HEPATITIS C; IMMUNOGENICITY; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; IONIC STRENGTH; LOW DRUG DOSE; MALIGNANT NEOPLASTIC DISEASE; MUSCLE CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PROSTATE CANCER; PROTEIN TARGETING; REVIEW; SOMATIC GENE THERAPY;

ANIMALS; CATTLE; DOGS; ELECTROPORATION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; HAPLORHINI; HUMANS; MICE; MODELS, ANIMAL; RABBITS; SWINE; VACCINES, DNA;

ANIMALIA; CANIS FAMILIARIS; SUIDAE;

EID: 70349971779     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652309788921062     Document Type: Review

References (123)

1. Onik G, Mikus P, Rubinsky B. Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 2007; 6(4): 295-300.
2. Esser AT, Smith KC, Gowrishankar TR, Weaver JC. Towards solid tumor treatment by irreversible electroporation: intrinsic redistribution of fields and currents in tissue. Technol Cancer Res Treat 2007; 6(4): 261-74.
3. Rubinsky B. Irreversible electroporation in medicine. Technol Cancer Res Treat 2007; 6(4): 255-60.
4. Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality - clinical implications. Technol Cancer Res Treat 2007; 6(1): 37-48.
5. Miller L, Leor J, Rubinsky B. Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 2005; 4(6): 699-705.
6. Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33(2): 223-31.
7. Al-Sakere B, Andre F, Bernat C, et al. Tumor ablation with irreversible electroporation. PLoS ONE 2007; 2(11): e1135.
8. Mir LM. Application of electroporation gene therapy: past, current, and future. Methods Mol Biol 2008; 423: 3-17.
9. Miyazaki M, Obata Y, Abe K, et al. Gene transfer using nonviral delivery systems. Perit Dial Int 2006; 26(6): 633-40.
10. Teissie J, Golzio M, Rols MP. Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge. Biochim Biophys Acta 2005; 1724(3): 270-80.
11. Gehl J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 2003; 177(4): 437-47.
12. Fewell JG. Factor IX gene therapy for hemophilia. Methods Mol Biol 2008; 423: 375-82.
13. Fewell JG, MacLaughlin F, Mehta V, et al. Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. Mol Ther 2001; 3(4): 574-83.
14. Daud AI, DeConti RC, Andrews S, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26(36): 5896-903.
15. Benz R, Zimmermann U. Pulse-length dependence of the electrical breakdown in lipid bilayer membranes. Biochim Biophys Acta 1980; 597(3): 637-42.
16. Benz R, Zimmermann U. The resealing process of lipid bilayers after reversible electrical breakdown. Biochim Biophys Acta 1981; 640(1): 169-78.
17. Chang DC, Reese TS. Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy. Biophys J 1990; 58(1): 1-12.
18. Knutson JC, Yee D. Electroporation: parameters affecting transfer of DNA into mammalian cells. Anal Biochem 1987; 164(1): 44-52.
19. Xie TD, Sun L, Tsong TY. Study of mechanisms of electric field-induced DNA transfection. I. DNA entry by surface binding and diffusion through membrane pores. Biophys J 1990; 58(1): 13-9.
20. Favard C, Dean DS, Rols MP. Electrotransfer as a non viral method of gene delivery. Curr Gene Ther 2007; 7(1): 67-77.
21. Neumann E, Kakorin S, Toensing K. Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem Bioenerg 1999; 48(1): 3-16.
22. Xie TD, Tsong TY. Study of mechanisms of electric field-induced DNA transfection. V. Effects of DNA topology on surface binding, cell uptake, expression, and integration into host chromosomes of DNA in the mammalian cell. Biophys J 1993; 65(4): 1684-9.
23. de Gennes PG. Passive entry of a DNA molecule into a small pore. Proc Natl Acad Sci USA 1999; 96(13): 7262-4.
24. Klenchin VA, Sukharev SI, Serov SM, Chernomordik LV, Chizmadzhev YuA. Electrically induced DNA uptake by cells is a fast process involving DNA electrophoresis. Biophys J 1991; 60(4): 804-11.
25. Sukharev SI, Klenchin VA, Serov SM, Chernomordik LV, Chizmadzhev YuA. Electroporation and electrophoretic DNA transfer into cells. The effect of DNA interaction with electropores. Biophys J 1992; 63(5): 1320-7.
26. Angelova MI, Hristova N, Tsoneva I. DNA-induced endocytosis upon local microinjection to giant unilamellar cationic vesicles. Eur Biophys J 1999; 28(2): 142-50.
27. Angelova MI, Tsoneva I. Interactions of DNA with giant liposomes. Chem Phys Lipids 1999; 101(1): 123-37.
28. Drinkwater NR, Klinedinst DK. Chemically induced mutagenesis in a shuttle vector with a low-background mutant frequency. Proc Natl Acad Sci USA 1986; 83(10): 3402-6.
29. Isaka Y, Imai E. Electroporation-mediated gene therapy. Expert Opin Drug Deliv 2007; 4(5): 561-71.
30. Thyagarajan B, Olivares EC, Hollis RP, Ginsburg DS, Calos MP. Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol 2001; 21(12): 3926-34.
31. Hollis RP, Nightingale SJ, Wang X, et al. Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon. Exp Hematol 2006; 34(10): 1333-43.
32. Chalberg TW, Vankov A, Molnar FE, et al. Gene transfer to rabbit retina with electron avalanche transfection. Invest Ophthalmol Vis Sci 2006; 47(9): 4083-90.
33. Ohta S, Suzuki K, Ogino Y, et al. Gene transduction by sonoporation. Dev Growth Differ 2008; 50(6): 517-20.
34. Skorpikova J, Dolnikova M, Hrazdira I, Janisch R. Changes in microtubules and microfilaments due to a combined effect of ultrasound and cytostatics in HeLa cells. Folia Biol (Praha) 2001; 47(4): 143-7.
35. Yamashita Y, Shimada M, Minagawa R, et al. Muscle-targeted interleukin-12 gene therapy of orthotopic hepatocellular carcinoma in mice using in vivo electrosonoporation. Mol Cancer Ther 2004; 3(9): 1177-82.
36. Yamashita Y, Shimada M, Tachibana K, et al. In vivo gene transfer into muscle via electro-sonoporation. Hum Gene Ther 2002; 13(17): 2079-84.
37. Mir LM, Bureau MF, Gehl J, et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999; 96(8): 4262-7.
38. Bettan M, Emmanuel F, Darteil R, et al. High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol Ther 2000; 2(3): 204-10.
39. Draghia-Akli R, Ellis KM, Hill LA, Malone PB, Fiorotto ML. High-efficiency growth hormone-releasing hormone plasmid vector administration into skeletal muscle mediated by electroporation in pigs. FASEB J 2003; 17(3): 526-8.
40. Lee MJ, Cho SS, Jang HS, et al. Optimal salt concentration of vehicle for plasmid DNA enhances gene transfer mediated by electroporation. Exp Mol Med 2002; 34(4): 265-72.
41. Nicol F, Wong M, MacLaughlin FC, et al. Poly-L-glutamate, an anionic polymer, enhances transgene expression for plasmids delivered by intramuscular injection with in vivo electroporation. Gene Ther 2002; 9(20): 1351-8.
42. Draghia-Akli R, Khan AS, Cummings KK, Parghi D, Carpenter RH, Brown PA. Electrical enhancement of formulated plasmid delivery in animals. Technol Cancer Res Treat 2002; 1(5): 365-72.
43. Quaglino E, Iezzi M, Mastini C, et al. Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice. Cancer Res 2004; 64(8): 2858-64.
44. Spadaro M, Ambrosino E, Iezzi M, et al. Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. Clin Cancer Res 2005; 11(5): 1941-52.
45. Maurer PH. Antigenicity of polypeptides (poly-alpha-amino acids). XVII. Immunologic studies in humans with polymers containing L or D and L-alpha-amino acids. J Immunol 1965; 95(6): 1095-9.
46. Hartikka J, Sukhu L, Buchner C, et al. Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188. Mol Ther 2001; 4(5): 407-15.
47. Mendiratta SK, Thai G, Eslahi NK, et al. Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2. Cancer Res 2001; 61(3): 859-63.
48. Cemazar M, Sersa G, Wilson J, et al. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector. Cancer Gene Ther 2002; 9(4): 399-406.
49. Draghia-Akli R, Khan AS, Brown PA, et al. Parameters for DNA vaccination using adaptive constant-current electroporation in mouse and pig models. Vaccine 2008; 26(40): 5230-7.
50. Muramatsu T, Nakamura A, Park HM. In vivo electroporation: a powerful and convenient means of nonviral gene transfer to tissues of living animals (Review). Int J Mol Med 1998; 1(1): 55-62.
51. Satkauskas S, Andre F, Bureau MF, Scherman D, Miklavcic D, Mir LM. Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer. Hum Gene Ther 2005; 16(10): 1194-201.
52. Satkauskas S, Bureau MF, Puc M, et al. Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis. Mol Ther 2002; 5(2): 133-40.
53. Hojman P, Gissel H, Andre F, et al. Physiological effects of high and low voltage pulse combinations for gene electrotransfer in muscle. Hum Gene Ther 2008; 1249-60.
54. Andre F, Gehl J, Sersa G, et al. Efficiency of high and low voltage pulse combinations for gene electrotransfer in muscle, liver, tumor and skin. Hum Gene Ther 2008; 1261-72.
55. Andre FM, Cournil-Henrionnet C, Vernerey D, Opolon P, Mir LM. Variability of naked DNA expression after direct local injection: the influence of the injection speed. Gene Ther 2006; 13(23): 1619-27.
56. Matsumoto T, Komori K, Shoji T, et al. Successful and optimized in vivo gene transfer to rabbit carotid artery mediated by electronic pulse. Gene Ther 2001; 8(15): 1174-9.
57. Tone CM, Cardoza DM, Carpenter RH, Draghia-Akli R. Long-term effects of plasmid-mediated growth hormone releasing hormone in dogs. Cancer Gene Ther 2004; 11(5): 389-96.
58. Bureau MF, Gehl J, Deleuze V, Mir LM, Scherman D. Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta 2000; 1474(3): 353-9.
59. Somiari S, Glasspool-Malone J, Drabick JJ, et al. Theory and in vivo application of electroporative gene delivery. Mol Ther 2000; 2(3): 178-87.
60. Brown PA, Khan AS, Draghia-Akli R. Delivery of DNA into skeletal muscle in large animals. Methods Mol Biol 2008; 423: 215-24.
61. Draghia-Akli R, Khan AS. Muscle and fat mass modulation in different clinical models. Methods Mol Biol 2008; 423: 449-60.
62. Draghia-Akli R, Fiorotto ML. A new plasmid-mediated approach to supplement somatotropin production in pigs. J Anim Sci 2004; 82 (E-Suppl): E264-9.
63. Brown PA, Davis WC, Draghia-Akli R. Immune-enhancing effects of growth hormone-releasing hormone delivered by plasmid injection and electroporation. Mol Ther 2004; 10(4): 644-51.
64. Draghia-Akli R, Malone PB, Hill LA, Ellis KM, Schwartz RJ, Nordstrom JL. Enhanced animal growth via ligand-regulated GHRH myogenic-injectable vectors. FASEB J 2002; 16(3): 426-8.
65. Pavlin D, Tozon N, Sersa G, Pogacnik A, Cemazar M. Efficient electrotransfection into canine muscle. Technol Cancer Res Treat 2008; 7(1): 45-54.
66. Draghia-Akli R, Cummings KK, Khan AS, Brown PA, Carpenter RH. Effects of plasmid-mediated growth hormone releasing hormone supplementation in young, healthy Beagle dogs. J Anim Sci 2003; 81(9): 2301-10.
67. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16(9): 867-70.
68. Tollefsen S, Vordermeier M, Olsen I, et al. DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants. Scand J Immunol 2003; 57(3): 229-38.
69. Scheerlinck JP, Karlis J, Tjelle TE, Presidente PJ, Mathiesen I, Newton SE. In vivo electroporation improves immune responses to DNA vaccination in sheep. Vaccine 2004; 22(13-14): 1820-5.
70. Khan AS, Smith LC, Abruzzese RV, et al. Optimization of electroporation parameters for the intramuscular delivery of plasmids in pigs. DNA Cell Biol 2003; 22(12): 807-14.
71. Babiuk S, Baca-Estrada ME, Foldvari M, et al. Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. J Biotechnol 2004; 110(1): 1-10.
72. Fattori E, Cappelletti M, Zampaglione I, et al. Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates. J Gene Med 2005; 7(2): 228-36.
73. Andre F, Mir LM. DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther 2004; 11 (Suppl 1): S33-42.
74. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247(4949 Pt 1): 1465-8.
75. Wu CJ, Lee SC, Huang HW, Tao MH. In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine. Vaccine 2004; 22(11-12): 1457-64.
76. Porgador A, Irvine KR, Iwasaki A, Barber BH, Restifo NP, Germain RN. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J Exp Med 1998; 188(6): 1075-82.
77. Medi BM, Singh J. Skin targeted DNA vaccine delivery using electroporation in rabbits II. Safety. Int J Pharm 2006; 308(1-2): 61-8.
78. Roos AK, Moreno S, Leder C, Pavlenko M, King A, Pisa P. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation. Mol Ther 2006; 13(2): 320-7.
79. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD, Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996; 2(10): 1122-8.
80. Ueda Y, Itoh T, Fuji N, et al. Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy. Cancer Immunol Immunother 2007; 56(3): 381-9.
81. Yen HH, Scheerlinck JP. Co-delivery of plasmid-encoded cytokines modulates the immune response to a DNA vaccine delivered by in vivo electroporation. Vaccine 2007; 25(14): 2575-82.
82. Park MY, Kim HS, Woo SJ, et al. Efficient antitumor immunity in a murine colorectal cancer model induced by CEA RNA-electroporated B cells. Eur J Immunol 2008; 38(8): 2106-17.
83. Onodera S, Ohshima S, Tohyama H, et al. A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis. Arthritis Rheum 2007; 56(2): 521-30.
84. Hosoi A, Takeda Y, Sakuta K, et al. Dendritic cell vaccine with mRNA targeted to the proteasome by polyubiquitination. Biochem Biophys Res Commun 2008; 371(2): 242-6.
85. Zhang X, Divangahi M, Ngai P, et al. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene. Vaccine 2007; 25(7): 1342-52.
86. Smooker PM, Rainczuk A, Kennedy N, Spithill TW. DNA vaccines and their application against parasites - promise, limitations and potential solutions. Biotechnol Annu Rev 2004; 10: 189-236.
87. Roman M, Martin-Orozco E, Goodman JS, et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997; 3(8): 849-54.
88. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 1997; 186(10): 1623-31.
89. Erhardt M, Gorschluter M, Sager J, et al. Transfection of human monocyte-derived dendritic cells with CpG oligonucleotides. Immunol Cell Biol 2005; 83(3): 278-85.
90. Kim CH, Yoon JS, Sohn HJ, et al. Direct vaccination with pseudotype baculovirus expressing murine telomerase induces anti-tumor immunity comparable with RNA-electroporated dendritic cells in a murine glioma model. Cancer Lett 2007 8; 250(2): 276-83.
91. Sasawatari S, Tadaki T, Isogai M, Takahara M, Nieda M, Kakimi K. Efficient priming and expansion of antigen-specific CD8+ T cells by a novel cell-based artificial APC. Immunol Cell Biol 2006; 84(6): 512-21.
92. Gilboa E, Vieweg J. Cancer immunotherapy with mRNA-transfected dendritic cells. Immunol Rev 2004; 199: 251-63.
93. Grunebach F, Muller MR, Brossart P. New developments in dendritic cell-based vaccinations: RNA translated into clinics. Cancer Immunol Immunother 2005; 54(6): 517-25.
94. Yu H, Babiuk LA, van Drunen Littel-van den Hurk S. Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA. Vaccine 2007; 25(10): 1701-11.
95. Zhao YG, Xu Y. Electroporation-mediated HBV DNA vaccination in primate models. Methods Mol Biol 2008; 423: 487-95.
96. Prud'homme GJ, Draghia-Akli R, Wang Q. Plasmid-based gene therapy of diabetes mellitus. Gene Ther 2007; 14(7): 553-64.
97. Tervo HM, Allespach I, Keppler OT. High-level transfection of primary rabbit T lymphocytes. J Immunol Methods 2008; 336(1): 85-9.
98. Chen NK, Wong JS, Kee IH, et al. Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical model. PLoS ONE 2008; 3(3): e1734.
99. Prud'homme GJ, Glinka Y, Khan AS, Draghia-Akli R. Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr Gene Ther 2006; 6(2): 243-73.
100. Meehan DT, Zink MA, Mahlen M, et al. Gene targeting in adult rhesus macaque fibroblasts. BMC Biotechnol 2008; 8: 31.
101. Norgren RB, Jr. Creation of non-human primate neurogenetic disease models by gene targeting and nuclear transfer. Reprod Biol Endocrinol 2004; 2: 40.
102. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299(5605): 411-4.
103. Lai L, Kolber-Simonds D, Park KW, et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295(5557): 1089-92.
104. Dai Y, Vaught TD, Boone J, et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002; 20(3): 251-5.
105. Denning C, Burl S, Ainslie A, et al. Deletion of the alpha( 1,3)galactosyl transferase (GGTA1) gene and the prion protein (PrP) gene in sheep. Nat Biotechnol 2001; 19(6): 559-62.
106. Piedrahita JA. Targeted modification of the domestic animal genome. Theriogenology 2000; 53(1): 105-16.
107. McCreath KJ, Howcroft J, Campbell KH, Colman A, Schnieke AE, Kind AJ. Production of gene-targeted sheep by nuclear transfer from cultured somatic cells. Nature 2000; 405(6790): 1066-9.
108. Yu G, Chen J, Yu H, et al. Functional disruption of the prion protein gene in cloned goats. J Gen Virol 2006; 87(Pt 4): 1019-27.
109. Shen SN, Xu Z, Qian XP, Ding YT, Yu LX, Liu BR. RNA-electroporated CD40-activated B cells induce functional T-cell responses against HepG2 cells. Eur J Cancer Care (Engl) 2008; 17(4): 404-11.
110. Kuroiwa Y, Kasinathan P, Matsushita H, et al. Sequential targeting of the genes encoding immunoglobulin-mu and prion protein in cattle. Nat Genet 2004; 36(7): 775-80.
111. Richt JA, Kasinathan P, Hamir AN, et al. Production of cattle lacking prion protein. Nat Biotechnol 2007; 25(1): 132-8.
112. Matsuki N, Ishikawa T, Imai Y, Yamaguchi T. Low voltage pulses can induce apoptosis. Cancer Lett 2008; 269(1): 93-100.
113. Gehl J, Geertsen PF. Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 2000; 10(6): 585-9.
114. Heller R, Jaroszeski M, Atkin A, et al. In vivo gene electroinjection and expression in rat liver. FEBS Lett 1996; 389(3): 225-8.
115. Gehl J. Electroporation for drug and gene delivery in the clinic: doctors go electric. Methods Mol Biol 2008; 423: 351-9.
116. Sersa G, Cemazar M, Parkins CS, Chaplin DJ. Tumour blood flow changes induced by application of electric pulses. Eur J Cancer 1999; 35(4): 672-7.
117. Takeshita S, Isshiki T, Sato T. Increased expression of direct gene transfer into skeletal muscles observed after acute ischemic injury in rats. Lab Invest 1996; 74(6): 1061-5.
118. Tsurumi Y, Takeshita S, Chen D, et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 1996; 94(12): 3281-90.
119. Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta 2002; 1569(1-3): 51-8.
120. Bromberg JS, Debruyne LA, Qin L. Interactions between the immune system and gene therapy vectors: bidirectional regulation of response and expression. Adv Immunol 1998; 69: 353-409.
121. Chen D, Ding Y, Zhang N, et al. Viral IL-10 gene transfer inhibits the expression of multiple chemokine and chemokine receptor genes induced by inflammatory or adaptive immune stimuli. Am J Transplant 2003; 3(12): 1538-49.
122. Qin J, Peng Z, McLeod MV. In vitro mutagenesis to define functional domains. Methods Mol Biol 2004; 241: 189-94.
123. Darquet AM, Rangara R, Kreiss P, et al. Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer. Gene Ther 1999; 6(2): 209-18.